# APROVE : Irbesartan in Hypertension

> **NCT00283036** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 200 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Irbesartan

## Key facts

- **NCT ID:** NCT00283036
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (—)
- **Last updated:** 2008-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283036, "APROVE : Irbesartan in Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00283036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*